Lord, Abbett & Co
XENT

Lord, Abbett & Co’s Intersect ENT, Inc XENT Stock Holding History

Lord, Abbett & Co’s Portfolio XENT Stock Details XENT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-379,322
Closed -$14.2M – 897
2018
Q2 		$14.2M Sell
379,322
-7,251
-2% -$285K 0.04% 553
2018
Q1 		$15.2M Buy
386,573
+26,596
+7% +$972K 0.05% 529
2017
Q4 		$11.7M Sell
359,977
-8,523
-2% -$256K 0.03% 599
2017
Q3 		$11.5M Buy
368,500
+32,743
+10% +$969K 0.03% 607
2017
Q2 		$9.38M Buy
+335,757
New +$7.6M 0.03% 645
2015
Q4 		– Sell
-1,081,869
Closed -$25.3M – 971
2015
Q3 		$25.3M Sell
1,081,869
-157,051
-13% -$4.33M 0.08% 361
2015
Q2 		$35.5M Buy
1,238,920
+866,394
+233% +$22.7M 0.09% 343
2015
Q1 		$9.62M Buy
372,526
+16,658
+5% +$381K 0.02% 631
2014
Q4 		$6.6M Buy
355,868
+2,463
+0.7% +$44.3K 0.02% 685
2014
Q3 		$5.48M Buy
+353,405
New +$5.32M 0.01% 726

Other funds holding XENT

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lord, Abbett & Co's XENT Position: Q3 2018 in Review

Lord, Abbett & Co sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 379,322 shares — an estimated $14.2M sold.

Lord, Abbett & Co first reported a position in XENT in Q3 2014 and held it in 10 quarters. The position peaked at $35.5M in Q2 2015. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Lord, Abbett & Co reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Lord, Abbett & Co sold 379,322 Intersect ENT, Inc shares in Q3 2018, an estimated $14.2M.
  • Lord, Abbett & Co first reported a position in Intersect ENT, Inc in Q3 2014 and held it in 10 quarters.
  • Lord, Abbett & Co's Intersect ENT, Inc position peaked at $35.5M in Q2 2015.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Lord, Abbett & Co's 13F filing for Q3 2018, filed 14 Nov 2018.